Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: West Pharmaceutical Services, Inc.

Market Cap 23.17B 401B 20.2B 18.71B 17.51B 32.85B 2,186B 33.05B 222B 86.02B 1,076B 86.97B 85.1B 3,736B P/E 2026 *
38.9x
P/E 2027 * 34.1x
Enterprise Value 22.43B 388B 19.55B 18.11B 16.95B 31.8B 2,116B 31.99B 215B 83.27B 1,042B 84.19B 82.38B 3,617B EV / Sales 2026 *
6.73x
EV / Sales 2027 * 6.26x
Free-Float
93.54%
Yield 2026 *
0.27%
Yield 2027 * 0.3%
1 year 4,128
Extreme 4128
5,112.51
3 years 4,000
Extreme 4000
7,104.95
5 years 4,000
Extreme 4000
9,649
10 years 4,000
Extreme 4000
9,649
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-23
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Change 5-day change 1-year change 3-year change Capi.($)
+15.28%-.--% - - 23.17B
-0.10%-1.38%-33.23%-16.75% 154B
+1.54%-1.23%-7.45%-11.00% 102B
-4.45%+6.22%+58.91%+55.60% 59.25B
-1.90%-3.43%-8.40%+48.53% 52.89B
+1.67%-2.29%-14.60%-44.33% 39.67B
-1.32%-3.20% - - 30.39B
+1.74%-3.69%-10.54%-44.30% 27.96B
-1.53%-1.74%-15.43%-3.81% 20.7B
-1.33%-7.95%-17.13%-40.94% 18.48B
Average +0.96%-1.00%-5.98%-7.12% 56.13B
Weighted average by Cap. +0.28%-0.34%-9.14%-3.52%

Financials

2026 *2027 *
Net sales 3.33B 57.69B 2.9B 2.69B 2.52B 4.72B 314B 4.75B 31.91B 12.37B 155B 12.51B 12.24B 537B 3.54B 61.26B 3.08B 2.86B 2.67B 5.02B 334B 5.05B 33.89B 13.13B 164B 13.28B 12.99B 570B
Net income 605M 10.47B 527M 488M 457M 857M 57.06B 862M 5.79B 2.25B 28.08B 2.27B 2.22B 97.52B 686M 11.87B 598M 554M 518M 972M 64.69B 978M 6.57B 2.55B 31.84B 2.57B 2.52B 111B
Net Debt -741M -12.84B -646M -599M -560M -1.05B -69.96B -1.06B -7.1B -2.75B -34.44B -2.78B -2.72B -120B -1.03B -17.77B -895M -829M -776M -1.46B -96.85B -1.46B -9.83B -3.81B -47.67B -3.85B -3.77B -166B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - proprietary products (80.7%); - - contract-manufactured products (19.3%). At the end of 2024, the group had 21 production sites worldwide. Net sales are distributed geographically as follows: the United States (42.5%), Germany (12.9%), Ireland (11.2%), France (8.4%), Europe (13.3%) and other (11.7%).
Employees
10,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
327.95USD
Average target price
358.79USD
Spread / Average Target
+9.40%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!